Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
2016 · New England Journal of Medicine · 1,764 citations
https://doi.org/10.1056/nejmoa1602773
S
Seymour Katz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
396
Papers
17.1K
Citations
62
h-index
149
i10-index
Seymour Katz is an academic researcher from NYU Langone Health. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 62, co-authored 337 publications.
ORCID: 0000-0002-3492-9200Papers by this author
worksA Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
2008 · Gastroenterology · 740 citations
https://doi.org/10.1053/j.gastro.2008.07.014
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
1993 · The Journal of Immunology · 507 citations
https://doi.org/10.4049/jimmunol.151.5.2390
Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro.
1995 · The Journal of Immunology · 177 citations
https://doi.org/10.4049/jimmunol.154.9.4851
Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
1989 · Journal of Lipid Research · 107 citations
https://doi.org/10.1016/s0022-2275(20)38207-9
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data
2019 · Scientific Reports · 106 citations
https://doi.org/10.1038/s41598-019-46649-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat